Healthcare - Biotechnology - NASDAQ - US
$ 1.04
-2.8 %
$ 3.36 M
Market Cap
-0.31
P/E
INCOME STATEMENT
0
REVENUE
-10.3 M
OPERATING INCOME
-10.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Artelo Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 10.3 M |
| Operating Income | -10.3 M |
| Other Expenses | -204 K |
| Net Income | -10.1 M |
Income Statement
Millions
| Dec-2022 | Aug-2021 | Aug-2020 | Aug-2019 | Aug-2018 | Aug-2017 | Aug-2016 | Aug-2015 | Aug-2014 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 10.3 | 7.4 | 4.7 | 3.2 | 2.3 | 0.2 | 29.7 K | 15.2 K | 15.3 K |
| Selling, General and Administrative Expenses | 6.0 | 4.6 | 2.8 | 2.1 | 1.1 | 0.2 | 29.7 K | 15.2 K | 15.3 K |
| Research and Development Expenses | 4.3 | 2.8 | 1.9 | 1.1 | 1.2 | 0 | 0 | 0 | 0 |
| Operating Income | (10.3) | (7.4) | (4.7) | (3.2) | (2.3) | (0.2) | 29.7 K | 15.2 K | 15.3 K |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 5 K | 0 | 0 | 0 | 0 | 2.1 K | 0 | 0 | 0 |
| Total Other Income | 0.2 | 2 K | 30.9 K | 1.0 | 0 | 2.1 K | 0 | 0 | 0 |
| Pre-Tax Income | (10.1) | (7.4) | (4.7) | (2.2) | (2.3) | (0.2) | 29.7 K | 15.2 K | 15.3 K |
| NET INCOME | |||||||||
| Tax Provision | (0.2) | 4 K | 60.4 K | (2.0) | 8 | 0 | 0 | 0 | 0 |
| Net Income | (9.9) | (7.4) | (4.7) | (2.2) | (2.3) | (0.2) | 29.7 K | 15.2 K | 15.3 K |
| EPS | 3.49 | 5.97 | 18.8 | 15 | 27.5 | 3.23 | 0.47 | 0.24 | 0.6 |